---
title: "180 Life Sciences (ATNF.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ATNF.US/norm.md"
symbol: "ATNF.US"
name: "180 Life Sciences"
parent: "https://longbridge.com/en/quote/ATNF.US.md"
datetime: "2026-05-20T12:58:22.617Z"
locales:
  - [en](https://longbridge.com/en/quote/ATNF.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ATNF.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ATNF.US/norm.md)
---

# 180 Life Sciences (ATNF.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.3025 | -0.6700 | -10.95 | -0.8532 | 0.0100 |
| ROE | -105.55% | -111.77% | -756.84% | -201.88% | -6.87% |
| Revenue | - | - | - | - | - |
| Net income | -1.73M | -2.37M | -12.29M | -836720.00 | 11781.00 |

## Balance Sheet (USD)

| Indicator | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 10.71M | 11.65M | 12.76M | 10.47M | 3.91M |
| Leverage | 1.99 | 1.51 | 1.38 | 2.80 | -9.36 |
| BVPS | 0.8909 | 1.49 | 2.91 | 3.64 | -0.4439 |
| Turnover | - | - | - | - | - |

## Cash Flow Statement (USD)

| Indicator | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -1.13M | -853723.00 | -950661.00 | -223659.00 | 727170.00 |
| Investing CF | - | - | - | - | - |
| Financing CF | -350000.00 | -3320.00 | 5.04M | -476065.00 | -264908.00 |
| Free CF | -1.45M | -217107.00 | -2.93M | 1.91M | -850995.00 |